Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

820results about How to "Low water solubility" patented technology

Method of treating vascular disease at a bifurcated vessel using a coated balloon

Disclosed is a method for delivery of at least one therapeutic agent from an angioplasty balloon for treating vascular disease at a bifurcated vessel. The invention also relates to the method of loading the beneficial agents onto the balloon and the device, as well as the method of delivery of the agents from separate surfaces. The invention also relates to a method of loading multiple beneficial agents onto the balloon surfaces
Owner:ABBOTT LAB INC

Porous drug matrices and methods of manufacture thereof

Drugs, especially low aqueous solubility drugs, are provided in a porous matrix form, preferably microparticles, which enhances dissolution of the drug in aqueous media. The drug matrices preferably are made using a process that includes (i) dissolving a drug, preferably a drug having low aqueous solubility, in a volatile solvent to form a drug solution, (ii) combining at least one pore forming agent with the drug solution to form an emulsion, suspension, or second solution and hydrophilic or hydrophobic excipients that stabilize the drug and inhibit crystallization, and (iii) removing the volatile solvent and pore forming agent from the emulsion, suspension, or second solution to yield the porous matrix of drug. Hydrophobic or hydrophilic excipients may be selected to stabilize the drug in crystalline form by inhibiting crystal growth or to stabilize the drug in amorphous form by preventing crystallization. The pore forming agent can be either a volatile liquid that is immiscible with the drug solvent or a volatile solid-compound, preferably a volatile salt. In a preferred embodiment, spray drying is used to remove the solvents and the pore forming agent. The resulting porous matrix has a faster rate of dissolution following administration to a patient, as compared to non-porous matrix forms of the drug. In a preferred embodiment, microparticles of the porous drug matrix are reconstituted with an aqueous medium and administered parenterally, or processed using standard techniques into tablets or capsules for oral administration.
Owner:ACUSPHERE INC

Porous drug matrices and methods of manufacture thereof

Drugs, especially low aqueous solubility drugs, are provided in a porous matrix form, preferably microparticles, which enhances dissolution of the drug in aqueous media. The drug matrices preferably are made using a process that includes (i) dissolving a drug, preferably a drug having low aqueous solubility, in a volatile solvent to form a drug solution, (ii) combining at least one pore forming agent with the drug solution to form an emulsion, suspension, or second solution and hydrophilic or hydrophobic excipients that stabilize the drug and inhibit crystallization, and (iii) removing the volatile solvent and pore forming agent from the emulsion, suspension, or second solution to yield the porous matrix of drug. Hydrophobic or hydrophilic excipients may be selected to stabilize the drug in crystalline form by inhibiting crystal growth or to stabilize the drug in amorphous form by preventing crystallization. The pore forming agent can be either a volatile liquid that is immiscible with the drug solvent or a volatile solid compound, preferably a volatile salt. In a preferred embodiment, spray drying is used to remove the solvents and the pore forming agent. The resulting porous matrix has a faster rate of dissolution following administration to a patient, as compared to non-porous matrix forms of the drug. In a preferred embodiment, microparticles of the porous drug matrix are reconstituted with an aqueous medium and administered parenterally, or processed using standard techniques into tablets or capsules for oral administration.
Owner:ACUSPHERE INC

Method for making ammonium polyphosphate clad by microcapsules

A microsoftgel coated ammonium polyphosphate is prepared through suspending the ammonium polyphosphate particles in disperser, adding melamine, formaldehyde and hardening agent at 60-150 deg.C, stirring while reaction, adding formaldehyde capture, stirring while reacting at 30-60 deg.C for 10-30 min, filtering and drying. It can be used as flame-retarding agent.
Owner:SHANGHAI RES INST OF CHEM IND

Method for preparing core-shell silicon dioxide-coated ammonium polyphosphate (APP)

The invention relates to a method for preparing core-shell silicon dioxide-coated ammonium polyphosphate (APP), which is characterized by comprising the following steps successively: (1) adding ammonium polyphosphate into ethanol water solution, stirring and dispersing well; (2) adding silicate ester ethanol solution into the solution obtained in the step (1) while the mass ratio of silicate ester to ammonium polyphosphate is 0.05-10:1, adjusting the pH value of the solution to 9-12 by adding alkaline solution, and then performing complete reaction at room temperature; and (3) adding couplingagent into the grout obtained in the step (2) to carry out surface treatment, and then filtrating, washing and drying to obtain the silicon dioxide-coated ammonium polyphosphate. On one hand, the ammonium polyphosphate flame retardant utilizes the synergistic flame retardance of silicon and phosphorus elements to increase retardant effectiveness and reduce dosage, thereby bringing down the negative effects of APP; on the other hand, the ammonium polyphosphate flame retardant utilizes the advantages of silicon dioxide, such as excellent hydrophobicity, heat resistance, high strength and the like, to further solve the problems of APP such as infiltration and migration, influence on product strength, insufficient heat resistance and the like.
Owner:浙江富锦新材料有限公司

Method for efficiently extracting lithium from salt lake brine

The invention relates to a method for efficiently extracting lithium from salt lake brine. The method comprises the following steps: (1) forming an extraction organic phase by an extraction agent, a co-extraction agent and a diluent, and then mixing the extraction organic phase with salt lake brine according to the volume ratio of (3-4):2 for three-stage extraction with single extraction time being 2-10 minutes to obtain an organic phase; and (2) mixing the organic phase obtained in step (1) with a reverse extraction acid solution (0-1 mol/L) for three-stage reverse extraction with single reverse extraction time being 2-10 minutes, and collecting an aqueous phase which is an aqueous solution containing lithium ions. The co-extraction agent of an extraction system of the method is hydrophobic ionic liquid, compared with conventional synergist ferric trichloride, the interference caused by iron ions is avoided, the reverse extraction acidity is greatly reduced, more importantly the lithium-magnesium separation factor is significantly improved, and the elution step of magnesium ions is reduced; in addition, the method provided by the invention is easy in process, easy to control, high in operation reliability, and good in recyclability of the organic phase, and greatly reduces the production cost for extracting the lithium from the salt lake brine.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Ammonium polyphosphate, montmorillonite nano complex and preparation thereof

The invention relates to an ammonium polyphosphate and montmorillonite nano compound and a preparation method thereof, which belong to the phosphorous compound preparation, composition, modification and crystalline control field. The method for preparing the nano compound comprises the following steps: montmorillonite is added during the preliminary stage of the process of general preparation of ammonium polyphosphate; ammonia is passed through when the temperature is raised to between 150 and 300 DEG C; heat preservation is performed when the temperature is raised to between 300 and 350 DEG C; and then the ammonium polyphosphate and montmorillonite nano compound are obtained after continuous ammoniation for 30 to 200 minutes. The preparation method controls the purity of an I-type polyphosphoric acid in the product through addition of a specific amount of the montmorillonite; the ammonium polyphosphate completely off a silicate slice of the montmorillonite; and nano-dispersion is formed in the ammonium polyphosphate, and then the ammonium polyphosphate and montmorillonite nano compound is obtained. The nano compound reduces the water solubility of the ammonium polyphosphate, has the function of improving the flame-retardant effect in inflaming retarding of polymer materials, and has the advantages of simple preparation technology and raw materials and low cost.
Owner:BEIJING INSTITUTE OF TECHNOLOGYGY

Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use

The present invention relates to novel amino acid salts of fumaric acid monoalkylesters. The salts are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders.
Owner:ADITECH PHARMA AG

Method for preparing complete water soluble low molecular weight chitosan/chitooligosaccharace

The disclosed preparation method for chitose / chitosan oligosaccharide with low molecular weight as 0.18-15mega and well water-solubility comprises: preparing water-soluble chitosan by acetylization; degrading the product with non-specific hydrolase while controlling the enzyme dosage and reaction time; adjusting the degraded product pH value to 8-9 with KOH or NaOH solution; depositing with ethanol, cleaning, and vacuum drying the final product with free amidogen that can promote wound healing, restrains tumor cell growth and improves human immunity. Compared with prior art, this invention is convenient to control for wide application.
Owner:WUHAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products